Skip to content
healthcare.dev

Depakote ER

NDC 0074-7401, Divalproex Sodium, tablet, extended release, from AbbVie Inc..

Product NDC
0074-7401
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021168
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7401 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIVALPROEX SODIUM250 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
0074-7401-1300074740113100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-7401-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0dc024ce-efc8-4690-7cb5-639c728fccac
  • NADAC price for package 00074740113

    GET /v1/drugs/nadac/00074740113

Use it

Look up 0074-7401 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-7401 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-7401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.